James L. Rogers

Array ( [id] => 10130274 [patent_doc_number] => 09164104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Relevance of achieved levels of markers of systemic inflammation following treatment' [patent_app_type] => utility [patent_app_number] => 11/244716 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16639 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11244716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10130274 [patent_doc_number] => 09164104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Relevance of achieved levels of markers of systemic inflammation following treatment' [patent_app_type] => utility [patent_app_number] => 11/244716 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16639 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11244716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794000 [patent_doc_number] => 20060014681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Three-dimensional structure of complement receptor type 2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/921415 [patent_app_country] => US [patent_app_date] => 2004-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 123960 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014681.pdf [firstpage_image] =>[orig_patent_app_number] => 10921415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834236 [patent_doc_number] => 20060246066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Cleavable reagents for specific delivery to disease sites' [patent_app_type] => utility [patent_app_number] => 10/499611 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9642 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246066.pdf [firstpage_image] =>[orig_patent_app_number] => 10499611 [rel_patent_id] =>[rel_patent_doc_number] =>)